Biblio

Export 172 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is X  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
P. Ding, Gorenflo, M. P., Zhu, X., and Xu, R., “Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.”, J Alzheimers Dis, vol. 92, no. 3, pp. 989-1000, 2023.
J. L. Del-Aguila, Fernández, M. Victoria, Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., Chasse, R., Harari, O., Goate, A., Xiong, C., Morris, J. C., and Cruchaga, C., “Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline.”, J Alzheimers Dis, vol. 62, no. 2, pp. 745-756, 2018.
X. - X. Liu, Wu, P. - F., Liu, Y. - Z., Jiang, Y. - L., Wan, M. - D., Xiao, X. - W., Yang, Q. - J., Jiao, B., Liao, X. - X., Wang, J. - L., Liu, S. - H., Zhang, X., and Shen, L., “Association Between Serum Vitamins and the Risk of Alzheimer's Disease in Chinese Population.”, J Alzheimers Dis, vol. 85, no. 2, pp. 829-836, 2022.
M. P. Gorenflo, Davis, P. B., Kendall, E. K., Olaker, V. R., Kaelber, D. C., and Xu, R., “Association of Aspirin Use with Reduced Risk of Developing Alzheimer's Disease in Elderly Ischemic Stroke Patients: A Retrospective Cohort Study.”, J Alzheimers Dis, vol. 91, no. 2, pp. 697-704, 2022.
L. M. Wright, Stein, T. D., Jun, G., Chung, J., McConnell, K., Fiorello, M., Siegel, N., Ness, S., Xia, W., Turner, K. L., and Subramanian, M. L., “Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1429-1438, 2019.
L. Wang, Davis, P. B., Volkow, N. D., Berger, N. A., Kaelber, D. C., and Xu, R., “Association of COVID-19 with New-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 2, pp. 411-414, 2022.
C. - H. Liu, Le Bu, X. -, Wang, J., Zhang, T., Xiang, Y., Shen, L. - L., Wang, Q. - H., Deng, B., Wang, X., Zhu, C., Yao, X. - Q., Zhang, M., Zhou, H. - D., and Wang, Y. - J., “The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1081-8, 2016.
L. Xie, Shinohara, R. T., Ittyerah, R., Kuijf, H. J., Pluta, J. B., Blom, K., Kooistra, M., Reijmer, Y. D., Koek, H. L., Zwanenburg, J. J. M., Wang, H., Luijten, P. R., Geerlings, M. I., Das, S. R., Biessels, G. Jan, Wolk, D. A., Yushkevich, P. A., and Wisse, L. E. M., “Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?”, J Alzheimers Dis, vol. 63, no. 1, pp. 217-225, 2018.
B
E. Schwertner, Pereira, J. B., Xu, H., Secnik, J., Winblad, B., Eriksdotter, M., Nägga, K., and Religa, D., “Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1307-1318, 2022.
S. Wang, He, B., Hang, W., Wu, N. H., Xia, L., Wang, X., Zhang, Q., Zhou, X., Feng, Z., Chen, Q., and Chen, J., “Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1385-1400, 2018.
A. Russu, Samtani, M. N., Xu, S., Adedokun, O. J., Lu, M., Ito, K., Corrigan, B., Raje, S., Liu, E., H Brashear, R., Styren, S., and Hu, C., “Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.”, J Alzheimers Dis, vol. 53, no. 2, pp. 535-46, 2016.
H. Li, Luo, X. - B., Xu, Y., and Hou, X. - Y., “A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus.”, J Alzheimers Dis, vol. 71, no. 2, pp. 671-684, 2019.
C
F. P. M. Oliveira, Moreira, A. Paula, de Mendonça, A., Verdelho, A., Xavier, C., Barroca, D., Rio, J., Cardoso, E., Cruz, Â., Abrunhosa, A., and Castelo-Branco, M., “Can 11C-PiB-PET Relative Delivery R1 or 11C-PiB-PET Perfusion Replace 18F-FDG-PET in the Assessment of Brain Neurodegeneration?”, J Alzheimers Dis, vol. 65, no. 1, pp. 89-97, 2018.
S. J. Fan, Xian, X. H., Li, L., Yao, X. G., Hu, Y. Y., Zhang, M., and Li, W. B., “Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1731-1743, 2018.
S. Chu, Xu, F., Su, Y., Chen, H., and Cheng, X., “Cerebral Amyloid Angiopathy (CAA)-Related Inflammation: Comparison of Inflammatory CAA and Amyloid-β-Related Angiitis.”, J Alzheimers Dis, vol. 51, no. 2, pp. 525-32, 2016.
K. Kawamura, Miyajima, M., Nakajima, M., Kanai, M., Motoi, Y., Nojiri, S., Akiba, C., Ogino, I., Xu, H., Kamohara, C., Yamada, S., Karagiozov, K., Ikeuchi, T., Kondo, A., and Arai, H., “Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 83, no. 1, pp. 179-190, 2021.
D. Li, Xie, Q., Xie, J., Ni, M., Wang, J., Gao, Y., Wang, Y., and Tang, Q., “Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 261-277, 2024.
D. Li, Xie, Q., Xie, J., Ni, M., Wang, J., Gao, Y., Wang, Y., and Tang, Q., “Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 261-277, 2024.
G. Silva Leandro, Evangelista, A. Feijó, Lobo, R. Rebouças, Xavier, D. Jordão, Moriguti, J. César, and Sakamoto-Hojo, E. Tiemi, “Changes in Expression Profiles Revealed by Transcriptomic Analysis in Peripheral Blood Mononuclear Cells of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1483-1495, 2018.
Q. - Q. Xu, Shan, C. - S., Wang, Y., Shi, Y. - H., Zhang, Q. - H., and Zheng, G. - Q., “Chinese Herbal Medicine for Vascular Dementia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials.”, J Alzheimers Dis, vol. 62, no. 1, pp. 429-456, 2018.
J. Sun, Cai, R., Huang, R., Wang, P., Tian, S., Sun, H., Xia, W., and Wang, S., “Cholesteryl Ester Transfer Protein Intimately Involved in Dyslipidemia-Related Susceptibility to Cognitive Deficits in Type 2 Diabetic Patients.”, J Alzheimers Dis, vol. 54, no. 1, pp. 175-84, 2016.
L. Xu, Zhang, W., Liu, X., Zhang, C., Wang, P., and Zhao, X., “Circulatory Levels of Toxic Metals (Aluminum, Cadmium, Mercury, Lead) in Patients with Alzheimer's Disease: A Quantitative Meta-Analysis and Systematic Review.”, J Alzheimers Dis, vol. 62, no. 1, pp. 361-372, 2018.
Q. Lin Chan, Xu, X., Shaik, M. Amin, Chong, S. Shih Tsze, Hui, R. Jor Yeong, Chen, C. Li- Hsian, and Dong, Y. H., “Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare.”, J Alzheimers Dis, vol. 49, no. 1, pp. 121-7, 2016.
L. Xiong, Davidsdottir, S., Reijmer, Y. D., Shoamanesh, A., Roongpiboonsopit, D., Thanprasertsuk, S., Martinez-Ramirez, S., Charidimou, A., Ayres, A. M., Fotiadis, P., Gurol, E., Blacker, D. L., Greenberg, S. M., and Viswanathan, A., “Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.”, J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
Y. Xia, Yassi, N., Raniga, P., Bourgeat, P., Desmond, P., Doecke, J., Ames, D., Laws, S. M., Fowler, C., Rainey-Smith, S. R., Martins, R., Maruff, P., Villemagne, V. L., Masters, C. L., Rowe, C. C., Fripp, J., and Salvado, O., “Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.”, J Alzheimers Dis, vol. 78, no. 1, pp. 321-334, 2020.

Pages